Pharmacokinetics and concentration–effect relationships of therapeutic monoclonal antibodies and fusion proteins-Reference-Cited by-同舟云学术

Pharmacokinetics and concentration–effect relationships of therapeutic monoclonal antibodies and fusion proteins

Published:2005-09-01 Issue:sup1 Volume:5 Page:S37-S47
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Ternant David¹,Paintaud Gilles¹

Affiliation:

1. François-Rabelais University, UPRES EA 3853 ‘Immuno-Pharmaco-Genetics of Therapeutic Antibodies’, Faculty of Medicine, 2 bis Boulevard Tonnellé, B.P. 3223, F 37032 Tours Cedex 1, France.

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1517/14712598.5.1.S37

Reference82 articles.

1. Continuous cultures of fused cells secreting antibody of predefined specificity

2. KHAZAELI MB, CONRY RIVI, LOBUGLIO AF: Human immune response to monoclonal antibodies. J. Immunother. (1994) 15(1):42–52. et al.: Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans. Cancer Res. (1991)

3. KHAZAELI MB, SALEH MN, LIU TP et al.: Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans. Cancer Res. (1991) 51(20):5461–5466.

4. BREED VELD FC: Therapeutic monoclonal antibodies. Lancet (2000) 355(9205):735–740. OWEN CE: Anti-immunoglobulin E therapy for asthma. Pulm. Pharmacol Ther. (2002) 15(5):417–424. VAISHNAW AK, TENHOOR CN: Pharmacokinetics, biologic activity, and tolerability of alefacept by intravenous and intramuscular administration. Pharmacokinet. Pharmacodyn. (2002) 29(5–6):415–426.

5. ECONOMIDES AN, CARPENTER LR, RUDGE JS et al.: Cytokine traps: multicomponent, high-affinity blockers of cytokine action. Nat. Med. (2003 (1):47–52.

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Antibodies: From Structure to Therapeutic Application;Pharmaceutical Biotechnology;2024

2. Precision medicine: Dose for anticancer therapy;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024

3. Preclinical Development of Monoclonal Antibodies;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024

4. Switching to Conbercept in Diabetic Macular Edema After Unsatisfactory Response to Previous Intravitreal Injection of Ranibizumab;Clinical Ophthalmology;2023-11

5. Monoclonal Antibodies in Nanosystems as a Strategy for Cancer Treatment;Cancer Nanotechnology;2022-12-14